02-27-2018 12:31 PM CET - Health & Medicine

Vaginal Atrophy Key Players – Novo A/S, Shionogi & Co Ltd, Quatrx Pharmaceutical Co and Pfizer Inc Market Analysis & Forecast 2017 to 2022

Press release from: WiseGuy Research consultants Pvt Ltd.
Vaginal Atrophy
Vaginal Atrophy
Vaginal Atrophy


Vaginal atrophy is thinning, drying and inflammation of the vaginal walls due to body having less estrogen. Signs and symptoms include vaginal dryness, vaginal discharge, genital itching, burning with urination, and urgency with urination, urinary tract infections and urinary incontinence.

Risk factor includes smoking. Smoking impairs blood circulation, depriving the vagina and other tissues of oxygen. Tissue thinning occurs where blood flow is decreased or restricted. Treatment includes topical (vaginal) estrogen and systemic estrogen therapy.

Click here for sample report @ www.wiseguyreports.com/sample-request/2627295-vaginal-atr...

Top Companies mentioned

Allergan Plc

Medinova AG

Mithra Pharmaceuticals SA

Sermonix Pharmaceuticals LLC

TherapeuticsMD Inc

Vaginal Atrophy Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Vaginal Atrophy  - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Vaginal Atrophy , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Vaginal Atrophy (Atrophic Vaginitis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Vaginal Atrophy (Atrophic Vaginitis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 2, 1, 1 and 1 respectively.

Vaginal Atrophy pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Vaginal Atrophy - Competitive Analysis

Key players are making innovative developments in Vaginal Atrophy industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Vaginal Atrophy.

The pipeline guide reviews pipeline therapeutics for Vaginal Atrophy by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Vaginal Atrophy therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Vaginal Atrophy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Vaginal Atrophy.


For Detailed Reading Please visit @ www.wiseguyreports.com/reports/2627295-vaginal-atrophy-at...

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.
News-ID: 959494 • Views: 225
More releasesMore releases

You can edit or delete your press release here: